BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35124870)

  • 1. Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes.
    Correia M; Silva I; Gabriel D; Simrén J; Carneiro A; Ribeiro S; Dória HM; Varela R; Aires A; Minta K; Antunes R; Felgueiras R; Castro P; Blenow K; Magalhães R; Zetterberg H; Maia LF
    Eur J Neurol; 2022 Jun; 29(6):1630-1642. PubMed ID: 35124870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy.
    Chen CH; Chu HJ; Hwang YT; Lin YH; Lee CW; Tang SC; Jeng JS
    J Neuroinflammation; 2021 Sep; 18(1):195. PubMed ID: 34511123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
    Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
    Eur Stroke J; 2024 Feb; ():23969873241234436. PubMed ID: 38400734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest.
    Arctaedius I; Levin H; Thorgeirsdóttir B; Moseby-Knappe M; Cronberg T; Annborn M; Nielsen N; Zetterberg H; Blennow K; Ashton NJ; Frigyesi A; Friberg H; Lybeck A; Mattsson-Carlgren N
    Crit Care; 2024 Apr; 28(1):116. PubMed ID: 38594704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients.
    Ferrari F; Rossi D; Ricciardi A; Morasso C; Brambilla L; Albasini S; Vanna R; Fassio C; Begenisic T; Loi M; Bossi D; Zaliani A; Alberici E; Lisi C; Morotti A; Cavallini A; Mazzacane F; Nardone A; Corsi F; Truffi M
    J Cereb Blood Flow Metab; 2023 Sep; 43(9):1601-1611. PubMed ID: 37113060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
    Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
    Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
    Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
    Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage.
    Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C
    Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
    Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
    Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy.
    Zang N; Lin Z; Huang K; Pan Y; Wu Y; Wu Y; Wang S; Wang D; Ji Z; Pan S
    Cerebrovasc Dis; 2020; 49(6):583-592. PubMed ID: 33105129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
    Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
    J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
    Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
    Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke.
    Liu G; Geng J
    Hum Exp Toxicol; 2018 Oct; 37(10):1048-1053. PubMed ID: 29308673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
    Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
    Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy.
    Yang Z; Xu H; Sura L; Arja RD; Patterson RL; Rossignol C; Albayram M; Rajderkar D; Ghosh S; Wang K; Weiss MD
    Pediatr Res; 2023 Apr; 93(5):1199-1207. PubMed ID: 35273370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.